Log in to save to my catalogue

1441 The glucocorticoid receptor (GR)-dependent regulations of chronic inflammation and NRF2 as emer...

1441 The glucocorticoid receptor (GR)-dependent regulations of chronic inflammation and NRF2 as emer...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0237f99f17e949a0b9ee6a34cafe27c7

1441 The glucocorticoid receptor (GR)-dependent regulations of chronic inflammation and NRF2 as emerging drug targets for cancer therapy

About this item

Full title

1441 The glucocorticoid receptor (GR)-dependent regulations of chronic inflammation and NRF2 as emerging drug targets for cancer therapy

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1604-A1604

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundOxidative stress resulting from chronic inflammation in the tumor microenvironment is a major contributing factor to cancer development. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that plays a key role in cellular defense against oxidative stress suggesting the critical role of NRF2 in tumor survival and...

Alternative Titles

Full title

1441 The glucocorticoid receptor (GR)-dependent regulations of chronic inflammation and NRF2 as emerging drug targets for cancer therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0237f99f17e949a0b9ee6a34cafe27c7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0237f99f17e949a0b9ee6a34cafe27c7

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2023-SITC2023.1441

How to access this item